AbraxaneTM is a nanoparticle albumin-bound formulation of paclitaxel (referred to as nab-PTX), that is currently used as the first-line treatment for advanced pancreatic cancer in combination with gemcitabine. The gene discussed is ALB; the disease is familial pancreatic carcinoma.